Carcinoid Syndrome: Clinical Trials

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 1, Terminated 1
Phase 2	1	Terminated 1

Follow Carcinoid Syndrome: new trials by email Literature Review of Carcinoid Syndrome trials Research Report on Carcinoid Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males 500 mg [14C]-LX1606 - Carcinoid Syndrome	Phase 1	Completed	Lexicon Pharmaceuticals	8	2013-08-01	2013-10-23
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome Octreotide - Carcinoid Syndrome	Phase 1 / Phase 2	Terminated	Endo USA Inc., a Keenova Therapeutics Company	10	2009-07-01	2013-09-20

Narrower conditions

Serotonin Syndrome (2)

Broader conditions

Chemically-Induced Disorders (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)

Interventions

Octreotide (1)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Lexicon Pharmaceuticals (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Doug Fleming, MD (1)